Paper Details

  1. Home
  2. Paper Details

Combination therapy of varenicline and bupropion in smoking cessation: A meta-analysis of the randomized controlled trials.

Author: XiaShuyue, ZhaoShijie, ZhaoYan, ZhongZhaoshuang

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.

Overview

Combining varenicline and bupropion for smoking cessation significantly improved abstinence rates, particularly in highly dependent and heavy smokers.
Paper Details　
Original Abstract of the Article :
BACKGROUND: The effects of the combination therapy of varenicline and bupropion in smoking cessation are still controversial. METHODS: Databases including PubMed, EMBASE, Cochrane Library and Web of Science were scanned without time and language limitation. Subgroup analysis was performed to assess...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.comppsych.2019.152125

データ提供：米国国立医学図書館（NLM）

Combination Therapy of Varenicline and Bupropion in Smoking Cessation: A Meta-Analysis of the Randomized Controlled Trials

Smoking cessation is a challenging endeavor, requiring a multifaceted approach to combat nicotine addiction. This study delves into the effectiveness of combining two popular smoking cessation medications, varenicline and bupropion, in a meta-analysis of randomized controlled trials. The research examines the impact of this combination therapy on abstinence rates and explores potential benefits for different groups of smokers based on their nicotine dependence and smoking habits.

Combating Nicotine Addiction: A Multifaceted Approach in the Desert of Smoking Cessation

This study highlights the potential benefits of combining varenicline and bupropion in smoking cessation therapy. The meta-analysis reveals a significant improvement in abstinence rates, particularly for highly dependent and heavy smokers. This research underscores the importance of tailoring smoking cessation interventions to individual needs and characteristics.

Navigating the Desert of Nicotine Addiction: A Personalized Approach to Smoking Cessation

This study offers valuable insights into the potential of combination therapy for smoking cessation, especially for highly dependent and heavy smokers. By highlighting the benefits of combining varenicline and bupropion, the research underscores the importance of personalized approaches to address the diverse needs and challenges of individuals seeking to quit smoking.

Dr. Camel's Conclusion

This study underscores the potential of combining varenicline and bupropion for smoking cessation, particularly for highly dependent and heavy smokers. The research highlights the importance of personalized approaches to address the unique challenges of nicotine addiction, promoting a more effective path towards smoke-free living.
Date :
  1. Date Completed 2020-05-18
  2. Date Revised 2020-05-18
Further Info :

Pubmed ID

31669972

DOI: Digital Object Identifier

10.1016/j.comppsych.2019.152125

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.